Osteoporosis Highlights
- Abstract 665: Active-Comparator Trial of Teriparatide Versus Alendronate in the Treatment of Glucocorticoid-Induced Osteoporosis
- Abstract 666: Efficacy and Safety of Zoledronic Acid 5 mg in Preventing Fractures in Men and Women With Prevalent Hip Fracture: The HORIZON-Recurrent Fracture Trial
- Abstract 2139: Bone Mineral Density Gains with Monthly Oral Ibandronate (150mg) and Weekly Oral Alendronate (70mg) After 12 months: Results from the MOTION Study
